Evidence map›Paper›PMID 27199673›Full record

ReviewFrontiers in neural circuits2016

Chandelier Cells in Functional and Dysfunctional Neural Circuits.

Yiqing Wang, Peng Zhang, Daniel R Wyskiel

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neural circuits, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Cortical control of chandelier cells in neural codes.Frontiers in cellular neuroscience · 2022
    Pooled it
  3. Article
  4. The Highly Localized Interaction between Neurofascin-186 and Gliomedin Promotes Subcellular Innervation by the Chandelier Cell.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  5. Cellular basis for cortical network aging in primates.bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Shaping functionality in the brain.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Molecular mechanisms of axo-axonic innervation.Current opinion in neurobiology · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. An unfolding role for ankyrin-G at the axon initial segment.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. Article
  18. Inhibitory Synapse Formation at the Axon Initial Segment.Frontiers in molecular neuroscience · 2019
    Article
  19. Axonal Computations.Frontiers in cellular neuroscience · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yiqing WangDepartment of Pharmacology, University of VirginiaCharlottesville, VA, USA; Department of Chemistry, University of VirginiaCharlottesville, VA, USA.
Peng ZhangDepartment of Pharmacology, University of Virginia Charlottesville, VA, USA.
Daniel R WyskielDepartment of Pharmacology, University of Virginia Charlottesville, VA, USA.
University of Virginia · US

Funding

Calcium channel and glutamate receptor signaling at synapsesR01NS091452 · NINDS · UNIVERSITY OF VIRGINIA · PI ZHU, J. JULIUS · 2015 to 2019
$1.7M
Synaptic Depression: Focus on Cdk5 SignalingR01NS092548 · NINDS · UNIVERSITY OF VIRGINIA · PI ZHU, J. JULIUS · 2015 to 2019
$1.7M
Interneuron-based cell therapy for Fragile XR21NS094980 · NINDS · UNIVERSITY OF VIRGINIA · PI ZHU, J. JULIUS · 2016 to 2017
$431k
NINDS NIH HHS R01 NS091452NINDS NIH HHS R01 NS092548NINDS NIH HHS R21 NS094980
6 · The paper itself

Abstract

Chandelier cells (ChCs; also called axo-axonic cells) are a specialized GABAergic interneuron subtype that selectively innervates pyramidal neurons at the axon initial segment (AIS), the site of action potential generation. ChC connectivity allows for powerful yet precise modulation of large populations of pyramidal cells, suggesting ChCs have a critical role in brain functions. Dysfunctions in ChC connectivity are associated with brain disorders such as epilepsy and schizophrenia; however, whether this is causative, contributory or compensatory is not known. A likely stumbling block toward mechanistic discoveries and uncovering potential therapeutic targets is the apparent lack of rudimentary understanding of ChCs. For example, whether cortical ChCs are inhibitory or excitatory remains unresolved, and thus whether altered ChC activity results in altered inhibition or excitation is not clear. Recent studies have shed some light onto this excitation-inhibition controversy. In addition, new findings have identified preferential cell-type connectivities established by cortical ChCs, greatly expanding our understanding of the role of ChCs in the cortical microcircuit. Here we aim to bring more attention to ChC connectivity to better understand its role in neural circuits, address whether ChCs are inhibitory or excitatory in light of recent findings and discuss ChC dysfunctions in brain disorders.

Indexed as

AnimalsAxonsBrain Diseasesgamma-Aminobutyric AcidNerve NetNeural InhibitionNeuronsgamma-Aminobutyric Acidaxo-axonic cellschandelier cellscircuitsepilepsyinterneuronschizophrenia

Identifiers

PMID27199673
PMCPMC4854894
OpenAlexW2346672341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.